Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 762426, 12 pages
http://dx.doi.org/10.1155/2015/762426
Research Article

Comparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5′ Terminus of Hepatitis C Virus RNA

1Latvian Biomedical Research and Study Center, Ratsupites Street 1, Riga LV-1067, Latvia
2N. F. Gamaleja Research Center of Epidemiology and Microbiology, Gamaleja Street 18, Moscow 123098, Russia
3Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Nobels Väg 16, 17177 Stockholm, Sweden
4Riga Stradins University, Dzirciema Street 16, Riga LV-1007, Latvia

Received 22 July 2015; Accepted 29 September 2015

Academic Editor: Masha Fridkis-Hareli

Copyright © 2015 Irina Sominskaya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Dahari, S. M. Feinstone, and M. E. Major, “Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins,” Gastroenterology, vol. 139, no. 3, pp. 965–974, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Fietta and G. Delsante, “The effector T helper cell triade,” Rivista di Biologia, vol. 102, no. 1, pp. 61–74, 2009. View at Google Scholar · View at Scopus
  3. N. Zhang and M. J. Bevan, “CD8+ T cells: foot soldiers of the immune system,” Immunity, vol. 35, no. 2, pp. 161–168, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. G. A. Elmowalid, M. Qiao, S.-H. Jeong et al., “Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 20, pp. 8427–8432, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Rollier, E. Depla, J. A. R. Drexhage et al., “Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response,” Journal of Virology, vol. 78, no. 1, pp. 187–196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. C. S. Rollier, G. Paranhos-Baccala, E. J. Verschoor et al., “Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity,” Hepatology, vol. 45, no. 3, pp. 602–613, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-W. Youn, S.-H. Park, D. Lavillette et al., “Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee,” Hepatology, vol. 42, no. 6, pp. 1429–1436, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J.-W. Youn, Y.-W. Hu, N. Tricoche et al., “Evidence for protection against chronic hepatitis C virus infection in chimpanzees by immunization with replicating recombinant vaccinia virus,” Journal of Virology, vol. 82, no. 21, pp. 10896–10905, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Alekseeva, I. Sominskaya, D. Skrastina et al., “Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen,” Genetic Vaccines and Therapy, vol. 7, article 7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Satoi, K. Murata, M. Lechmann et al., “Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins,” Journal of Virology, vol. 75, no. 24, pp. 12121–12127, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. O. Vidalin, M. Muslmani, C. Estienne, H. Echchakir, and A. M. Abina, “In vivo target validation using gene invalidation, RNA interference and protein functional knockout models: it is the time to combine,” Current Opinion in Pharmacology, vol. 9, no. 5, pp. 669–676, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Vidalin, A. Fournillier, N. Renard et al., “Use of conventional or replicating nucleic acid-based vaccines and recombinant semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens,” Virology, vol. 276, no. 2, pp. 259–270, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Rehermann, “Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence,” The Journal of Clinical Investigation, vol. 119, no. 7, pp. 1745–1754, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. G.-J. Hu, R. Y.-H. Wang, D.-S. Han, H. J. Alter, and J. W.-K. Shih, “Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization,” Vaccine, vol. 17, no. 23-24, pp. 3160–3170, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Geissler, K. Tokushige, T. Wakita, V. R. Zurawski Jr., and J. R. Wands, “Differential cellular and humoral immune responses to HCV core and HBV envelope proteins after genetic immunizations using chimeric constructs,” Vaccine, vol. 16, no. 8, pp. 857–867, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Geissler, A. Gesien, K. Tokushige, and J. R. Wands, “Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids,” Journal of Immunology, vol. 158, no. 3, pp. 1231–1237, 1997. View at Google Scholar · View at Scopus
  17. S.-H. Park and B. Rehermann, “Immune responses to HCV and other hepatitis viruses,” Immunity, vol. 40, no. 1, pp. 13–24, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. J. G. Bode, E. D. Brenndörfer, and D. Häussinger, “Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response,” Biological Chemistry, vol. 389, no. 10, pp. 1283–1298, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Hiroishi, T. Ito, and M. Imawari, “Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence,” Journal of Gastroenterology and Hepatology, vol. 23, no. 10, pp. 1473–1482, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Q. Yao, E. King, D. Prayther, D. Yin, and J. Moorman, “T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling,” Viral Immunology, vol. 20, no. 2, pp. 276–287, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. G. J. Dawson, “The potential role of HCV core antigen testing in diagnosing HCV infection,” Antiviral Therapy, vol. 17, no. 7, pp. 1431–1435, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. H. L. Tillmann, “Hepatitis C virus core antigen testing: role in diagnosis, disease monitoring and treatment,” World Journal of Gastroenterology, vol. 20, no. 22, pp. 6701–6706, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. C. J. Kroger and M. A. Alexander-Miller, “Dose-dependent modulation of CD8 and functional avidity as a result of peptide encounter,” Immunology, vol. 122, no. 2, pp. 167–178, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Hashempour, T. Bamdad, A. Bergamini et al., “F protein increases CD4+CD25+ T cell population in patients with chronic hepatitis C,” Pathogens and Disease, vol. 73, no. 4, 2015. View at Publisher · View at Google Scholar
  25. M. Yue, X. Deng, X. Zhai et al., “Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients,” Immunology Letters, vol. 152, no. 2, pp. 89–95, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. W. C.-M. Chuang and J.-P. Allain, “Differential reactivity of putative genotype 2 hepatitis C virus F protein between chronic and recovered infections,” Journal of General Virology, vol. 89, no. 8, pp. 1890–1900, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Komurian-Pradel, A. Rajoharison, J.-L. Berland et al., “Antigenic relevance of F protein in chronic hepatitis C virus infection,” Hepatology, vol. 40, no. 4, pp. 900–909, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Kong, X. Deng, Z. Wang, J. Yang, Y. Zhang, and J. Yu, “Hepatitis C virus F protein: a double-edged sword in the potential contribution of chronic inflammation to carcinogenesis,” Molecular Medicine Reports, vol. 2, no. 3, pp. 461–469, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. A. D. Branch, D. D. Stump, J. A. Gutierrez, F. Eng, and J. L. Walewski, “The hepatitis C virus alternate reading frame (ARF) and its family of novel products: the alternate reading frame protein/F-protein, the double-frameshift protein, and others,” Seminars in Liver Disease, vol. 25, no. 1, pp. 105–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Rispeter, M. Lu, S. Lechner, A. Zibert, and M. Roggendorf, “Cloning and characterization of a complete open reading frame of the hepatitis C virus genome in only two cDNA fragments,” Journal of General Virology, vol. 78, part 11, pp. 2751–2759, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. V. V. Mokhonov, D. V. Novikov, E. I. Samokhvalov et al., “Genome analysis of hepatitis C virus strain 274933RU isolated in Russian Federation,” Voprosy Virusologii, vol. 47, no. 1, pp. 9–12, 2002. View at Google Scholar · View at Scopus
  32. N. V. Petrakova, T. I. Kalinina, I. Khudiakov, E. V. Gazina, and V. D. Smirnov, “Preparation and purification of a polypeptide containing antigenic determinants of hepatitis C core protein,” Voprosy Virusologii, vol. 42, no. 5, pp. 208–212, 1997. View at Google Scholar
  33. M. Mihailova, M. Fiedler, M. Boos et al., “Preparation of hepatitis C virus structural and non-structural protein fragments and studies of their immunogenicity,” Protein Expression and Purification, vol. 50, no. 1, pp. 43–48, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. M. G. Isaguliants, K. Iakimtchouk, N. V. Petrakova et al., “Gene immunization may induce secondary antibodies reacting with DNA,” Vaccine, vol. 22, no. 11-12, pp. 1576–1585, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Guide for the Care and Use of Laboratory Animals, National Academies Press, Washington, DC, USA, 8th edition, 2011.
  36. Y. E. Khudyakov, H. A. Fields, M. O. Favorov, N. S. Khudyakova, M.-T. Bonafonte, and B. Holloway, “Synthetic gene for the hepatitis C virus nucleocapsid protein,” Nucleic Acids Research, vol. 21, no. 11, pp. 2747–2754, 1993. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Wahren, J. Hinkula, E. Ljungdahl Stahle, C. A. K. Borrebaeck, S. Schwartz, and H. Wigzell, “Nucleic acid vaccination with HIV regulatory genes,” Annals of the New York Academy of Sciences, vol. 772, pp. 278–281, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. M. G. Isaguliants, S. Nordlund, M. Sallberg et al., “HIV-1 epitopes exposed by hybrid hepatitis B core particles affect proliferation of peripheral blood mononuclear cells from HIV-1 positive donors,” Immunology Letters, vol. 52, no. 1, pp. 37–44, 1996. View at Google Scholar
  39. K. Yasui, T. Wakita, K. Tsukiyama-Kohara et al., “The native form and maturation process of hepatitis C virus core protein,” Journal of Virology, vol. 72, no. 7, pp. 6048–6055, 1998. View at Google Scholar · View at Scopus
  40. R. Suzuki, K. Tamura, J. Li et al., “Ubiquitin-mediated degradation of hepatitis C virus core protein is regulated by processing at its carboxyl terminus,” Virology, vol. 280, no. 2, pp. 301–309, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Vassilaki and P. Mavromara, “The HCV ARFP/F/Core+1 protein: production and functional analysis of an unconventional viral product,” IUBMB Life, vol. 61, no. 7, pp. 739–752, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Baril and L. Brakier-Gingras, “Translation of the F protein of hepatitis C virus is initiated at a non-AUG codon in a +1 reading frame relative to the polyprotein,” Nucleic Acids Research, vol. 33, no. 5, pp. 1474–1486, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Boulant, M. Becchi, F. Penin, and J.-P. Lavergne, “Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b,” The Journal of Biological Chemistry, vol. 278, no. 46, pp. 45785–45792, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Boumlic, Y. Nominé, S. Charbonnier et al., “Prevalence of intrinsic disorder in the hepatitis C virus ARFP/Core+1/S protein,” FEBS Journal, vol. 277, no. 3, pp. 774–789, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Vassilaki and P. Mavromara, “Two alternative translation mechanisms are responsible for the expression of the HCV ARFP/F/core+1 coding open reading frame,” The Journal of Biological Chemistry, vol. 278, no. 42, pp. 40503–40513, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. H.-C. Li, H.-C. Ma, C.-H. Yang, and S.-Y. Lo, “Production and pathogenicity of hepatitis C virus core gene products,” World Journal of Gastroenterology, vol. 20, no. 23, pp. 7104–7122, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Varaklioti, N. Vassilaki, U. Georgopoulou, and P. Mavromara, “Alternate translation occurs within the core coding region of the hepatitis C viral genome,” Journal of Biological Chemistry, vol. 277, no. 20, pp. 17713–17721, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. Z. Xu, J. Choi, T. S. B. Yen et al., “Synthesis of a novel hepatitis C virus protein by ribosomal frameshift,” The EMBO Journal, vol. 20, no. 14, pp. 3840–3848, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. V. Barban, S. Fraysse-Corgier, G. Paranhos-Baccala et al., “Identification of a human epitope in hepatitis C virus (HCV) core protein using a molecularly cloned antibody repertoire from a non-symptomatic, anti-HCV-positive patient,” Journal of General Virology, vol. 81, no. 2, pp. 461–469, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Sällberg, U. Rudén, B. Wahren, and L. O. Magnius, “Immune response to a single peptide containing an immunodominant region of hepatitis C virus core protein: the isotypes and the recognition site,” Immunology Letters, vol. 33, no. 1, pp. 27–33, 1992. View at Publisher · View at Google Scholar · View at Scopus
  51. F. Baghbani-arani, F. Roohvand, M. R. Aghasadeghi et al., “Expression and characterization of Escherichia coli derived hepatitis C virus ARFP/F protein,” Journal of Molekuliarnaia Biologiia, vol. 46, no. 2, pp. 251–259, 2012. View at Google Scholar · View at Scopus
  52. C. Bain, P. Parroche, J. P. Lavergne et al., “Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection,” Journal of Virology, vol. 78, no. 19, pp. 10460–10469, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. D.-Y. Gao, X.-X. Zhang, G. Hou et al., “Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin,” Journal of Clinical Microbiology, vol. 46, no. 11, pp. 3746–3751, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Qureshi, R. Qazi, S. Hamid, and S. A. Qureshi, “Identification of immunogenic regions within the alternative reading frame protein of hepatitis C virus (genotype 3),” European Journal of Clinical Microbiology and Infectious Diseases, vol. 30, no. 9, pp. 1075–1083, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. K. M. Shesheer, R. K. Venkateswara, H. C. Mohammed, and V. D. Reddy, “Expression of alternate reading frame protein (F1) of hepatitis C virus in Escherichia coli and detection of antibodies for F1 in Indian patients,” Infection, Genetics and Evolution, vol. 8, no. 3, pp. 374–377, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. M. U. Mondelli, A. Cerino, F. Bono et al., “Hepatitis C virus (HCV) core serotypes in chronic HCV infection,” Journal of Clinical Microbiology, vol. 32, no. 10, pp. 2523–2527, 1994. View at Google Scholar · View at Scopus
  57. F. H. Pujol, Y. E. Khudyakov, M. Devesa et al., “Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome,” Viral Immunology, vol. 9, no. 2, pp. 89–96, 1996. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Siemoneit, M. da Silva Cardoso, A. Wölpl et al., “Isotype-specific immune response to a single hepatitis C virus core epitope defined by a human monoclonal antibody: diagnostic value and correlation to PCR,” Annals of Hematology, vol. 69, no. 3, pp. 129–133, 1994. View at Publisher · View at Google Scholar · View at Scopus
  59. J. L. Walewski, T. R. Keller, D. D. Stump, and A. D. Branch, “Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame,” RNA, vol. 7, no. 5, pp. 710–721, 2001. View at Publisher · View at Google Scholar · View at Scopus
  60. I. Harase, T. Moriyama, T. Kaneko et al., “Immune response to hepatitis C virus core protein in mice,” Immunology and Cell Biology, vol. 73, no. 4, pp. 346–352, 1995. View at Publisher · View at Google Scholar · View at Scopus
  61. K. Kakimi, K. Kuribayashi, M. Iwashiro et al., “Hepatitis C virus core region: helper T cell epitopes recognized by BALB/c and C57BL/6 mice,” Journal of General Virology, vol. 76, no. 5, pp. 1205–1214, 1995. View at Publisher · View at Google Scholar · View at Scopus
  62. M. G. Shehat, M. Bahey-El-Din, M. A. Kassem, F. A. Farghaly, M. H. Abdul-Rahman, and N. H. Fanaki, “Recombinant expression of the alternate reading frame protein (ARFP) of hepatitis C virus genotype 4a (HCV-4a) and detection of ARFP and anti-ARFP antibodies in HCV-infected patients,” Archives of Virology, vol. 160, no. 8, pp. 1939–1952, 2015. View at Publisher · View at Google Scholar
  63. P. Skums, L. Bunimovich, and Y. Khudyakov, “Antigenic cooperation among intrahost HCV variants organized into a complex network of cross-immunoreactivity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 21, pp. 6653–6658, 2015. View at Publisher · View at Google Scholar
  64. A. V. Ivanov, O. A. Smirnova, I. Y. Petrushanko et al., “HCV core protein uses multiple mechanisms to induce oxidative stress in human hepatoma huh7 cells,” Viruses, vol. 7, no. 6, pp. 2745–2770, 2015. View at Publisher · View at Google Scholar
  65. R. I. Fisher and F. Bostick-Bruton, “Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide,” Journal of Immunology, vol. 129, no. 4, pp. 1770–1774, 1982. View at Google Scholar · View at Scopus
  66. C. Nathan and A. Cunningham-Bussel, “Beyond oxidative stress: an immunologist's guide to reactive oxygen species,” Nature Reviews Immunology, vol. 13, no. 5, pp. 349–361, 2013. View at Publisher · View at Google Scholar
  67. Y. Yang, A. V. Bazhin, J. Werner, and S. Karakhanova, “Reactive oxygen species in the immune system,” International Reviews of Immunology, vol. 32, no. 3, pp. 249–270, 2013. View at Publisher · View at Google Scholar · View at Scopus
  68. J. Cachat, C. Deffert, S. Hugues, and K. Krause, “Phagocyte NADPH oxidase and specific immunity,” Clinical Science, vol. 128, no. 10, pp. 635–648, 2015. View at Publisher · View at Google Scholar
  69. S. Reiche, C. Nestler, M. Sieg et al., “Hepatitis C virus (HCV)-specific memory B-cell responses in transiently and chronically infected HIV positive individuals,” Journal of Clinical Virology, vol. 59, no. 4, pp. 218–222, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Ward, G. Lauer, R. Isba, B. Walker, and P. Klenerman, “Cellular immune responses against hepatitis C virus: the evidence base 2002,” Clinical and Experimental Immunology, vol. 128, no. 2, pp. 195–203, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. M. A. A. Claassen, H. L. A. Janssena, and A. Boonstra, “Role of T cell immunity in hepatitis C virus infections,” Current Opinion in Virology, vol. 3, no. 4, pp. 461–467, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Sillanpää, K. Melén, P. Porkka et al., “Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection,” Virology Journal, vol. 6, article 84, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. L. Alvarez-Lajonchere, N. H. Shoukry, B. Grá et al., “Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase i clinical trial,” Journal of Viral Hepatitis, vol. 16, no. 3, pp. 156–167, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Lechmann and T. J. Liang, “Vaccine development for hepatitis C,” Seminars in Liver Disease, vol. 20, no. 2, pp. 211–226, 2000. View at Publisher · View at Google Scholar · View at Scopus
  75. W. Zhu, C. Wu, W. Deng et al., “Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo,” PLoS ONE, vol. 7, no. 9, Article ID e45146, 2012. View at Publisher · View at Google Scholar · View at Scopus